3651 results for «217»
3651 results
Leaflet modification techniques during TAVI
19 May 2026 – From EuroPCR 2026
This session explores leaflet modification techniques during TAVI, focusing on complex valve-in-valve procedures supported by artificial intelligence-powered planning and advanced imaging. Case discussions cover challenges such as low valve-to-coronary distances, bi-leaflet obstruction, and strategies to maintain coronary flow and hemodynamic stability.
Pulmonary valve: the next frontier in adult structural interventions
19 May 2026 – From EuroPCR 2026
This session highlights the evolving role of the pulmonary valve in adult structural interventions. It reviews complex transcatheter pulmonary valve replacement (TPVR) cases, strategies for managing challenging right ventricular outflow tract anatomies, and percutaneous solutions for pulmonary artery stenosis and related complications.
New techniques and tips in CTO PCI
19 May 2026 – From EuroPCR 2026
This session presents new techniques and practical tips in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers innovative approaches such as the side-flap technique, simplified antegrade strategies for calcified lesions, and retrograde CTO techniques, providing valuable insights into overcoming challenging occlusions.
Clinical cases - Nurses and Allied Professionals
19 May 2026 – From EuroPCR 2026
Dedicated to nurses and allied health professionals, this session presents compelling clinical cases illustrating their critical role in interventional cardiology. Topics range from managing pregnant patients in the cath lab, the impactful contributions of nursing and allied professionals (NAPs), to their management perspectives during complex procedures...
From left to right: different perspectives on heart failure management
19 May 2026 – From EuroPCR 2026
Exploring diverse perspectives on heart failure management, this session presents a range of complex clinical cases. Topics include facilitated treatment of post-myocardial infarction interventricular septal defects, left ventricular perforation following Impella placement, diagnostic challenges in shock scenarios, the implications of severe right ventricular dysfunction on left...
Rescue PCI for acute or unusual left main lesions
19 May 2026 – From EuroPCR 2026
This session explores rescue PCI techniques for acute and unusual left main coronary lesions, highlighting complex cases such as left main compression syndrome in pulmonary hypertension, and challenging strategies in acute coronary syndromes with left main occlusion and anatomical variations.
Interventional therapy for hypertension
19 May 2026 – From EuroPCR 2026
This session addresses interventional therapies for hypertension, emphasizing patient selection for renal denervation and integration of this technique within comprehensive hypertension management. It also reviews available renal denervation technologies, optimal procedural approaches, and considerations for interventional treatment of renal artery stenosis.
Complication management in CTO PCI - Part 1
19 May 2026 – From EuroPCR 2026
This session addresses complication management during chronic total occlusion (CTO) percutaneous coronary interventions. It covers strategies for unexpected coronary complications, managing tamponade without visible perforation, rescue techniques for atherectomy-related perforations, managing dry pericardial tamponade after septal branch perforation, and challenges when retrograde approaches encounter thrombosis in...
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona
Author
TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
31 Aug 2024
Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.
Simultaneous publication in European Heart Journal, ehae578
Author
EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES
14 May 2024